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Abstract
Background:  This study takes an in depth look at embryonic development, implantation,
pregnancy and live birth rates with frozen epididymal and testicular sperm from obstructed (OA)
and non-obstructed (NOA) patients.
Methods: Paternal effect of sperm source on zygote formation, embryonic cleavage, and genomic
activation were examined. Additional outcome parameters monitored were clinical pregnancy rate
(CPR), implantation rate (IR) and live birth rate.
Results:  In this report, we retrospectively analyzed 156 ICSI cycles using cryopreserved
epididymal sperm (ES; n = 77) or testicular sperm (TESE; n = 79). The developmental potential of
embryos did not appear to be influenced by the type of surgically retrieved sperm. The average
number of blastomeres observed on Day 3 was not different among different groups; 7.5 +/- 1.7
(ES), 7.6 +/- 2.1 (TESE-OA) and 6.5 +/- 2.3 (TESE-NOA). Compaction and blastulation rates, both
indicators of paternal genomic activation, were similar in embryos derived from ICSI with ES or
TESE from OA as well as NOA men. The only parameter significantly affected in NOA-TESE cases
was the fertilization rate. CPR and IR with cryopreserved TESE (TESE-OA 59%, 34%, and TESE-
NOA 37%, 20%) were also not statistically different, from that achieved with cryopreserved ES
(61% and 39%). Live birth rates also appeared to be independent of sperm type. The 87 clinical
pregnancies established using cryopreserved TESE and ES, resulted in the birth of 115 healthy
infants. No congenital anomalies were noted.
Conclusion: Zygotic activation seems to be independent of sperm origin and type of azoospermia.
Background
Male factor infertility represents almost one third of infer-
tility cases, of which azoospermia may comprise up
to10% of cases [1]. Azoospermia can be either obstructive
(OA) or non-obstructive (NOA). In OA there is a blockage
in the reproductive pathway of sperm. In such cases,
sperm can be retrieved from the epididymis or the testis.
With NOA, spermatogenesis itself is impaired and sperm
is not usually obtainable from the epididymis necessitat-
ing testicular sperm retrieval [2-5]. In severe cases, there
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may only be scattered foci of sperm production and more
extensive biopsy may be necessary to recover tubules with
sperm.
Paternal contribution may affect fertilization, early
embryo development, genomic activation and ultimately
clinical pregnancy. The sperm centrosome is directly
involved in forming the sperm aster and organizing the
mitotic spindle and plays an important role in early
embryonic development (reviewed in [6]). Microtubules,
extending from centrioles, are responsible for proper pro-
nuclei movement and fusion [7], as well as pronuclei
alignment. Certain types of male infertility and fertiliza-
tion arrest may be related to the sperm centrosome [8].
Data have suggested an association between centriolar
defects and sperm immotility or non progressive motility
[9].
Severe male factor cases requiring surgical retrieval of
sperm from the epididymis or testis present a unique
opportunity to further study the paternal influence on
embryonic development. Paternal genome expression
and resultant zygotic activation occurs at the 4-8 cell stage
in human embryos [10]. A question of obvious interest to
reproductive specialists in treating males with severe
azoospermia is whether the source of sperm or type of
azoospermia affects embryonic development and subse-
quent outcomes.
This study takes an in depth look at embryonic develop-
ment and clinical outcomes with frozen epididymal (ES)
and testicular (TESE) sperm from OA and NOA patients
coming through our IVF program. Paternal genome acti-
vation in ICSI embryos is gauged using embryonic com-
paction and blastulation as morphologic indicators of the
onset of zygotic transcription. We also present live birth
data from pregnancies established with cryopreserved sur-
gically retrieved sperm.
Methods
Study population
We retrospectively analyzed 156 consecutive ICSI cycles
performed at the Cleveland Clinic using cryopreserved ES
and TESE during the period from January 2001 to Decem-
ber 2007. Azoospermia was classified as OA or NOA
based on history, physical examination, FSH levels and
surgical findings by the urologist. Specifically, patients
with normal testicular volume and ductal anatomy in
conjunction with normal gonadotropin levels or a history
of known genital tract obstruction such as vasectomy were
classified as OA. In addition, patients with a prior normal
diagnostic testicular biopsy were assigned to the OA
group. Patients with reduced testicular volume and ele-
vated gonadotropin levels or prior testis biopsy revealing
compromised spermatogenesis were classified as NOA.
All NOA patients received standard genetic testing with
karyotype and y-linked microdeletion analysis. All results
were normal in our study population. The data for this
study was collected via retrospective chart review, in
accordance with guidelines of our Institutional Review
Board.
Epididymal and testicular sperm preparation and 
cryopreservation
Male partners had sperm extracted and cryopreserved
prior to IVF cycle start. ES were extracted using either per-
cutaneous sperm aspiration or micro-surgical epididymal
sperm aspiration technique. The specimen was assessed
under an inverted microscope at 300×. A small 5 μl aliq-
uot was placed on a petri dish and overlaid with oil. Total
motile sperm per high powered field (hpf) were counted.
At least 10 fields were evaluated. If no sperm were seen in
the initial sampling, additional aliquots were examined.
Testicular sperm extraction procedures were performed by
the reproductive urologist at our ambulatory surgical unit.
Sperm was extracted from testicular tissue by homogeni-
zation with a Kontes pestle and release of sperm into
modified human tubal fluid medium (m HTF, Irvine)
supplemented with10% human serum albumin (HSA,
SAGE). Multiple samples from different sites within one
or both testes were taken, until either sperm were
observed or else the operating surgeon determined that no
more tissue could be safely removed. The number of
motile sperm per hpf was recorded for each sample.
For cryopreservation, ES and TESE samples were diluted
1:1 with test yolk buffer-glycerol cryoprotectant (Irvine)
and aliquotted into cryovials. Vials were vapor frozen for
30 minutes prior to immersion in liquid nitrogen. Based
on number of sperm viewed per hpf, 4-8 vials were frozen
per patient, each being sufficient for a single IVF cycle. A
separate 25 μl "test" aliquot was frozen to assess post-
thaw survival. If no motile sperm were observed on test-
thaw, the patient was counseled. The option of donor
sperm back-up and oocyte freezing were discussed.
Ovulation induction and oocyte retrieval
Down regulation with leuprolide acetate (Lupron; TAP,
Pharmaceuticals, Lake Forest, IL) followed by ovulation
induction with gonadotrophins was the primary stimula-
tion protocol utilized. Human chorionic gonadotrophin
(hCG) was administered when at least two follicles meas-
ured 18 mm in diameter. Oocyte retrieval using trans-vag-
inal ultrasound guided follicle puncture was performed
36 hours later. The luteal phase was supported with intra-
muscular progesterone (50 mg/ml). Cumulus-oocyte
complexes were cultured in microdrops of HTF medium
(LifeGlobal, Guilford, CT) supplemented with 10 mg/mlReproductive Biology and Endocrinology 2009, 7:142 http://www.rbej.com/content/7/1/142
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of HSA under an oil overlay. Culture dishes were incu-
bated at 37°C with 5.5% CO2.
Thawing of epididymal/testicular sperm and ICSI
Cumulus-oocyte complexes were briefly exposed to
hyaluronidase (SAGE) to facilitate removal of the sur-
rounding cumulus cells and to allow evaluation of oocyte
nuclear maturity. Mature metaphase II oocytes were
injected with thawed epididymal or testicular sperm
between 3 and 8 hours after the oocyte retrieval.
Frozen epididymal and testicular sperm specimens were
thawed at room temperature and examined for the pres-
ence of motile sperm. Specimens with at least one motile
sperm per hpf were washed by centrifugation at 200 g for
10 minutes. Sperm pellet was re-suspended in 50-100 μl
of mHTF with 10 mg/ml of HSA. Centrifugation was
avoided in cases with very low numbers of motile sperma-
tozoa. In these cases the sample was serially diluted to
remove the cryoprotectant and facilitate sperm identifica-
tion and isolation. Motile or twitching sperm were prefer-
entially selected for ICSI. If enough motile or twitching
sperm could not be isolated after several hours of search-
ing, sperm with distinctly flexible tails were sometimes
considered for injection.
Attention was paid to sperm head morphology during the
selection process. Sperm heads were cleared of any sur-
rounding debris by repeated aspiration and expulsion
from the ICSI needle to allow clear visualization and pre-
vent inadvertent injection of motile sperm with tiny, irreg-
ular or pin heads. The sperm were collected in a media
drop in the ICSI dish and moved to 10% polyvinylpyro-
lidone (PVP, Medicult, Denmark) prior to injection. Time
spent by sperm in the PVP drop prior to injection was
minimized.
Embryo evaluation and transfer
Fertilization check was performed 18-20 hours after the
ICSI procedure. Normally fertilized zygotes exhibiting
two pronuclei were subsequently moved to microdrops
containing HTF supplemented with 10% Synthetic Serum
Substitute (SSS; Irvine, CA) and cultured for an additional
two days. Embryo cleavage and development were moni-
tored daily. Global blastocyst medium with 10% SSS was
used for extended culture to the blastocyst stage.
Embryo transfer was generally performed on Day 3 using
a Wallace catheter under ultrasound guidance. Embryo
selection for Day 3 transfer was based on morphologic
parameters. Embryos were graded on the basis of cell
number, regularity of blastomeres, good blastomere
expansion, fragmentation level and signs of embryonic
compaction or increased cell:cell adherence.
In 13 of the cycles studied, total zygote number and
embryo quality were high, allowing a shift to a Day 5
transfer. Embryo selection on Day 5 was based on blasto-
cyst maturity, trophectoderm and ICM differentiation
[11]. Non-transferred embryos were either frozen on Day
3 or placed in extended culture and frozen on Day 5 or 6
at the blastocyst stage.
Pregnancy testing was performed 15 days after the embryo
transfer. Clinical pregnancy was confirmed by the pres-
ence of a fetal heart on ultrasound examination at six to
eight weeks of pregnancy. Live birth and delivery informa-
tion was obtained from clinical records.
Data collection/statistical analysis
The primary outcome measures tabulated were fertiliza-
tion rate, cleavage rate, Day 3 cell number, compaction,
blastocyst formation, number of embryos transferred,
clinical pregnancy rate and implantation rate. The
implantation rate was calculated by dividing the number
of fetal heart tones by the total number of embryos trans-
ferred. Multiple pregnancy and live birth rates were also
monitored. Results are expressed as means ± SD for
numeric variables. Categorical variables were expressed as
proportions (%). Mean values were compared using the
one way-ANOVA test and the Student's t-test for numeric
variables. Proportions were compared using the chi-
square test or the Fisher's exact test, depending on sample
size. P-values of less than 0.05 were considered to be sta-
tistically significant.
Results
We retrospectively analyzed 156 consecutive IVF cycles
performed at the Cleveland Clinic and utilized frozen-
thawed ES or TESE for ICSI of mature oocytes. Cryopre-
served-thawed ES were used in 75 cycles; while 79 ICSI
cycles were performed using cryopreserved TESE. Neither
the female (31.9 ± 4 and 32.8 ± 3.6) nor the male (39 ±
8.6 and 38.5 ± 7.0) ages differed significantly between the
ES versus the TESE treatment groups, respectively. Male
diagnosis for azoospermia and surgical sperm extraction
is shown in Table 1. OA accounted for 75% of the cycles
in the TESE group. In the ES treatment group, all but one
case was OA.
Table 2 summarizes results from cases using frozen ES ver-
sus TESE sperm. The average number of oocytes injected
with sperm was 11.2 ± 5.5, 10.8 ± 6.0 and 9.8 ± 4.0 in
cycles using ES and TESE sperm from OA and NOA men,
respectively (Table 2). Fertilization rate was significantly
lower in the TESE-NOA cases (50% vs 66% TESE-OA and
65% ES).
The primary limitation to successful ICSI was the identifi-
cation and isolation of sufficient numbers of motile and/Reproductive Biology and Endocrinology 2009, 7:142 http://www.rbej.com/content/7/1/142
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or twitching sperm from the thawed specimen. Injection
of clearly motile sperm, exhibiting slight head movement
or twitching was essential for success. In this series, we
completely failed to find motile sperm in two cycles, one
with ES and the other with TESE sperm from a NOA
patient. Injection of immotile sperm did not result in fer-
tilization. Cell number on Day 3, in the cohort of embryos
selected for transfer did not differ significantly with sperm
type used for ICSI (ES: 7.5 ± 1.7; TESE-OA: 7.6 ± 2.1 and
TESE-NOA: 6.5 ± 2.3). Embryos were carefully monitored
for signs of increased cell:cell adherence and compaction
as a part of the selection process for transfer. We found
that approximately 11% of non-transferred embryos
within both groups were of a quality suitable for freezing
on Day 3. Remaining supernumerary embryos were cul-
tured for 2-3 additional days and monitored for compac-
tion and blastocyst development (Table 3). ICSI with ES
or TESE sperm from OA and NOA men resulted in similar
rates of embryonic compaction and blastulation. These
data suggest that paternal genome activation was not
influenced by either the source of sperm or the type of
azoospermia.
Table 1: Azoospermia and male diagnosis
Male Diagnosis Epididymal TESE (OA) TESE (NOA)
Total Males 59 44 17
Vasectomy 26 12
Congenital bilateral absence of vas deferens 16 6
Ejaculatory dysfunction 3 1
Infective/inflammatory 2
Non infective 3 2
Idiopathic 8 23 3
Germ cell aplasia 1 3
Incomplete maturation arrest 2
Mixed germ cell aplasia and maturation arrest 2
Hypospermatogenesis 5
Testicular carcinoma 1
Atrophy of seminiferous tubules 1
* None of the NOA patient had Klinefelter's syndrome or chromosome Y microdeletions
Table 2: Comparison of cycle outcome parameters after ICSI with epididymal or testicular sperm from males with obstructive (OA) 
and non-obstructive (NOA) azoospermia
Sperm Type Epididymal Testicular
Obstructive
OA
Testicular
Non Obstructive
NOA
P value
Number of retrieval cycles 77 59 20 -
Number of transfers 75 58 19 -
Male partner age 39.0 ± 8.6 39.3 ± 7.5 36.0 ± 4.8 NS
Maternal age 31.9 ± 4.0 32.9 ± 3.5 32.3 ± 4.0 NS
Average number of oocytes 14.0 ± 5.8 14.2 ± 6.2 13.5 ± 7.3 NS
Average oocytes injected 11.2 ± 5.5 10.8 ± 6.0 9.8 ± 4.0 NS
Average oocytes fertilized 7.2 ± 4.4 7.3 ± 4.0 4.9 ± 4.0 0.06
Fertilization rate 65% 66% 50%a < 0.001
Cleavage rate 97% 99% 97% NS
Average embryos transferred 2.2 ± 0.6 2.5 ± 0.7b 2.2 ± 0.8 < 0.05
Average cells on Day 3 7.5 ± 1.7 7.6 ± 2.1 6.5 ± 2.3 NS
Clinical pregnancy rate 61% 59% 37% NS
Implantation rate 39% 34% 20% NS
Deliveries (n) 46 33 7 -
Singleton (n) 32 22 6 -
Twins (n) 12 10 1 -
Triplets (n) 2 1 0 -
Boys (n) 31 23 5 -
Girls (n) 31 22 3 -
Miscarriages (n) 0 1 0 -
a Significantly different from ES and TESE-OA
b Significantly different from ES and TESE-NOAReproductive Biology and Endocrinology 2009, 7:142 http://www.rbej.com/content/7/1/142
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Clinical pregnancy was achieved by 46 couples (61%), 34
couples (59%) and 7 couples (37%) using ES, TESE-OA
and TESE-NOA, respectively. Eight patients using thawed
ES for ICSI were transferred on Day 5 and seven became
pregnant. Day 5 transfers in the TESE group were per-
formed for 5 patients and all 5 achieved a clinical preg-
nancy. The average number of embryos transferred was
significantly higher with TESE-OA cases (2.5 ± 0.7 versus
TESE-NOA 2.2 ± 0.8 and ES 2.2 ± 0.6; P < 0.05). The
implantation potential of embryos arising from TESE
sperm in OA cases (34%) was not statistically different
than that from ES group (39%). Although key outcome
parameters, namely clinical pregnancy and implantation
rates were lower in the TESE-NOA group, the differences
were not statistically significant. Nineteen patients had an
implantation failure on their first cycle and 15 success-
fully achieved a pregnancy on a subsequent IVF cycle
(TESE group 7/9; ES group 8/10).
The delivery rate between the groups was similar. Forty six
pregnancies were established using frozen ES and resulted
in a delivery of 62 healthy infants (32 singletons, 12 sets
of twins and 2 triplet pregnancies). In the frozen TESE
group, 40 of 41 clinical pregnancies delivered, resulting in
the birth of 53 healthy infants (28 singletons, 11 twin and
1 triplet pregnancy). One pregnancy resulted in a sponta-
neous abortion. No congenital anomalies or major mal-
formations were noted.
Discussion
This comparative study of ICSI outcomes with cryopre-
served ES and TESE sperm from males with OA and NOA
provides insight in to the developmental capacity of such
embryos and paternal effect on genome activation. The
high implantation rate per embryo transferred and the
resultant live births attest to the quality of embryos being
produced with both types of surgically retrieved sperm.
Azoospermia cases present an opportunity to study pater-
nal effect on genomic activation and clinical outcome
parameters. The sperm centrosome is directly involved in
forming the sperm aster and organizing the mitotic spin-
dle. Microtubules, extending from centrioles, are respon-
sible for proper pronuclei movement and fusion [7], as
well as pronuclei alignment. Both centrioles that are nec-
essary for completion of the fertilization step are contrib-
uted by the sperm. Zygote expression of mRNA transcripts
has been shown to begin at approximately the 4 to 8 cell
stage [10,12]. This represents a critical transition point for
human embryos- the point at which the paternal genome
is believed to be activated [13]. Disruptions in sperma-
togenesis might be expected to alter paternal genome
expression. One of the earliest morphologic indicators of
embryonic genome activation in in vitro cultured embryos
is increased cell:cell adherence at the 8-cell stage, leading
to compaction [14]. The arrest of ICSI embryos at the 5-8
cell, close to the time of genome activation [13,15] and
lower blastulation rates have been attributed to sperm
defects [16-19].
Limited reports detail embryonic development in vitro
and clinical prognosis in OA versus NOA TESE cases [20-
24]. Data from the present work, suggest that sperm ori-
gin; epididymal versus testicular does not significantly
affect cell number on Day 3, clinical pregnancy outcome
and implantation rates. Patients with NOA did however
have significantly lower fertilization rates. This may be
indicative of limited foci of sperm production, resulting in
lower numbers of motile sperm for selection, along with
dysfunctional spermatogenesis in these NOA cases.
Interestingly, embryonic compaction was similar in all
three groups (Table 3). About 2/3 of embryos derived
from surgically retrieved sperm transitioned past the early
cleavage stage and exhibited signs of compaction suggest-
ing that paternal genome activation was independent of
the type of azoospermia. Rates of blastocyst formation in
supernumerary embryos was also not statistically different
(ES 38%, TESE-OA 42% and TESE-NOA 38%), supporting
this argument. Balaban et al (2001) using fresh ES and
TESE sperm also concluded that the type of azoospermia
(OA or NOA) did not appear to influence blastulation
[25].
Our findings are in agreement with other published
reports observing no impact of NOA on clinical preg-
nancy and implantation rates [22,25-28]. In contrast, Ver-
naeve et al [29] obtained lower pregnancy (15% vs 24%)
as well as implantation (9% vs 13%) rates in TESE cases
with an etiology of NOA versus OA, respectively. A meta-
Table 3: Development of embryos not transferred or frozen on Day 3
Epididymal Testicular OA Testicular
NOA
Number of embryos 349 224 48
Embryos undergoing compaction 74% 69% 79%
Embryos undergoing blastulation 38% 42% 38%
Comparison of embryos derived from ICSI with epididymal sperm and testicular sperm (obstructive azoospermia;OA) and non-obstructive 
azoopermia (NOA). Development expressed as percentage of total embryos left in extended culture. No significant differences were observed.Reproductive Biology and Endocrinology 2009, 7:142 http://www.rbej.com/content/7/1/142
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analysis published by Nicopoullos et al. (2004), also sug-
gests impaired implantation rates in NOA cases [30].
Clearly, severity of the spermatogenesis defect, techno-
logic aspects of handling such cases as well as other etio-
logical factors may potentially influence the degree of
success with TESE specimens from males with NOA.
The technique for effective utilization of frozen surgically
retrieved sperm adopted by our laboratory deserves some
mention. Assessment and quantitation of pre and post-
thaw motility on a test aliquot in all cases involving surgi-
cally retrieved sperm was invaluable in cycle manage-
ment. The IVF laboratory could then anticipate the
difficult cases, arrange for more personnel and extra time
for screening. Technical aspects of the ICSI procedure
itself were also vital to success when dealing with the
extremely impaired specimens. Great care was taken to
select sperm with distinct motility or head motion and to
avoid injection of sperm with dysmorphisms. These data
encourage us to advocate this approach in all but the most
extreme cases.
Conclusion
This study examined not only clinical outcomes with sur-
gically retrieved sperm but also paternal contribution to
embryonic development. The observations on embryonic
compaction suggest that zygotic activation is independent
of sperm origin and type of azoospermia. A limitation of
the current study is the number of NOA patients. The rela-
tionship between specific male diagnosis and paternal
genomic activation in NOA needs to be looked at in a
larger data series. Such data may be useful in understand-
ing paternal factors correlating to embryonic arrest espe-
cially in cases with severe defects in spermatogenesis.
Finally, recognition of the importance of compaction and
preferential selection of embryos with this attribute for
transfer may play a role in achieving high implantation
rates with surgically retrieved sperm.
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